FFA
ACAD icon

Farther Finance Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Farther Finance Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$182K Buy
9,023
+8,200
+996% +$220K ﹤0.01% 2372
2026
Q2 		$20.8K Buy
823
+331
+67% +$7.28K ﹤0.01% 3932
2026
Q1 		$11K Sell
492
-466
-49% -$11.1K ﹤0.01% 4043
2025
Q4 		$25.6K Buy
958
+386
+67% +$9.22K ﹤0.01% 3274
2025
Q3 		$12.2K Sell
572
-271
-32% -$6.41K ﹤0.01% 3348
2025
Q2 		$18.2K Buy
843
+509
+152% +$9.46K ﹤0.01% 2743
2025
Q1 		$5.45K Hold
334
– – ﹤0.01% 3017
2024
Q4 		$6.13K Buy
334
+45
+16% +$726 ﹤0.01% 2576
2024
Q3 		$4.45K Hold
289
– – ﹤0.01% 2694
2024
Q2 		$4.64K Sell
289
-1,455
-83% -$23.5K ﹤0.01% 2428
2024
Q1 		$31.8K Hold
1,744
– – ﹤0.01% 1343
2023
Q4 		$54.6K Buy
1,744
+1,490
+587% +$35.6K ﹤0.01% 1006
2023
Q3 		$5.29K Hold
254
– – ﹤0.01% 1502
2023
Q2 		$6.08K Hold
254
– – ﹤0.01% 1358
2023
Q1 		$4.78K Hold
254
– – ﹤0.01% 1356
2022
Q4 		$4.04K Buy
+254
New +$3.97K ﹤0.01% 1238

Other funds holding ACAD

GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Farther Finance Advisors's ACAD Position: Q3 2026 in Review

Farther Finance Advisors increased its Acadia Pharmaceuticals (ACAD) stake by 996% in Q3 2026, buying an estimated $220K and bringing the position to 9,023 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2372.

Farther Finance Advisors first reported a position in ACAD in Q4 2022 and has held it in 16 quarters since. 10 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Farther Finance Advisors held 9,023 shares of Acadia Pharmaceuticals worth $182K as of Q3 2026.
  • Farther Finance Advisors bought 8,200 Acadia Pharmaceuticals shares in Q3 2026, an estimated $220K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2372 holding.
  • Farther Finance Advisors first reported a position in Acadia Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • 10 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.